| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/26/2011 | CN101953796A Method for preparing recombinant human endostatin chitosan nanoparticles for injection |
| 01/26/2011 | CN101953795A Drug delivery nanodevice, its preparation method and uses thereof |
| 01/26/2011 | CN101953794A Silibinin injection and preparation method thereof |
| 01/26/2011 | CN101953792A Irinotecan nano circulating liposome and preparation method thereof |
| 01/26/2011 | CN101953791A Capsule containing cefprozil liposome and preparation method thereof |
| 01/26/2011 | CN101953789A Dry suspension containing cefprozil liposome and preparation method thereof |
| 01/26/2011 | CN101953788A Cefprozil liposome-containing dispersible tablet and preparation method thereof |
| 01/26/2011 | CN101953787A Tablet containing cefprozi liposome and preparation method thereof |
| 01/26/2011 | CN101953786A 3', 5'-cyclocytidine dilaurate ether lipsome and preparation method thereof |
| 01/26/2011 | CN101953785A Myricetin microemulsion type preparation and preparation method thereof |
| 01/26/2011 | CN101953783A Preparation process of troxerutin injection |
| 01/26/2011 | CN101953782A Production method for dopamine hydrochloride injection |
| 01/26/2011 | CN101953780A Cefprozil solid preparation and preparation method thereof |
| 01/26/2011 | CN101953779A Medical disinfection gel |
| 01/26/2011 | CN101953778A Folate-targeted hydrophobic medicine-loaded polymeric vesicle and preparation method and use thereof |
| 01/26/2011 | CN101953776A Non-spherical drug-loaded particles and controlled release preparation of lactyl polymer and preparation methods thereof |
| 01/26/2011 | CN101953775A Hydrogel nanoparticles used as injectable subcutaneous implant agent |
| 01/26/2011 | CN101953774A 2-methoxy estradiol injectable hydrogel implant |
| 01/26/2011 | CN101953773A Lamivudine liposome solid preparation |
| 01/26/2011 | CN101669961B Method for producing Chinese-western compound preparation for preventing and treating animal synthetic respiratory diseases |
| 01/26/2011 | CN101612128B Alginic acid inorganic nanometer composite gel microspheres and preparation method |
| 01/26/2011 | CN101559039B Method for producing nattokinase liposome from phytosterol |
| 01/26/2011 | CN101543476B A naringin solid dispersion and the preparation method, and the application thereof |
| 01/26/2011 | CN101530399B Silibinin solid self-emusifying tablet |
| 01/26/2011 | CN101485886B Blood platelet additive solution and preparation method thereof |
| 01/26/2011 | CN101475640B Conjugate, and preparation and use thereof |
| 01/26/2011 | CN101474406B Mono-layer oxidized mineral carbon and ferriferrous oxide composite material as well as preparation and application |
| 01/26/2011 | CN101440379B Obtaining method and use of novel oncolytic adenovirus construct with selective tumor blockage STAT3 |
| 01/26/2011 | CN101427994B Gemcitabine-containing anti-cancer medicine sustained-release injection |
| 01/26/2011 | CN101422457B Tiotropium bromide respirable dry powder composition |
| 01/26/2011 | CN101272809B Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents |
| 01/26/2011 | CN101259082B Root canal anti-inflammation developing agent and preparation thereof |
| 01/26/2011 | CN101240002B Fatty acylaminoacylcytarabine conjugate, preparation method and application thereof |
| 01/26/2011 | CN101239098B Inclusion peppermint oil and manufacture method thereof |
| 01/26/2011 | CN101181235B Tantudinun sustained-release implantation agent for curing entity tumour |
| 01/26/2011 | CN101181231B Sustained-release implantation agent of urotrotiken |
| 01/26/2011 | CN101107014B Stabilisation of glucocorticoid esters with acids |
| 01/26/2011 | CN101066259B Solid dispersion of higher fatty alcohol and its prepn |
| 01/25/2011 | USRE42072 High transport rates of hormones delivered across cell membranes, facilitating more efficient delivery of drugs and diagnostic agents by using a viscous fluid comprising a polysaccharide a form of hydrogel, lipogel or sols; drug delivery to mucous membranes; gastrointesinal systems |
| 01/25/2011 | US7875677 Micellar drug delivery systems for hydrophobic drugs |
| 01/25/2011 | US7875590 using an injectable or implantable rod-shaped formulation for delivery of osteogenic proteins to treat osteoporotic and/or osteopenic bone; bone morphogenic proteins |
| 01/25/2011 | US7875588 Methods of therapy using pharmaceutical composition for thrombin peptide derivatives |
| 01/25/2011 | US7875450 Virus-like particles for the induction of autoantibodies |
| 01/25/2011 | US7875310 Residual solvent extraction method and microparticles produced thereby |
| 01/25/2011 | US7875292 Orally disintegrable tablets |
| 01/25/2011 | US7875291 Nutritional supplement, for managing metabolic disorders; first formulation including minerals e.g magnesium glycinate, manganese sulfate, selenium, vanadyl sulfate), zinc gluconate), copper gluconate, iodine, boron and various vitamins; second pacakge include esssential fatty acid; dosage form |
| 01/25/2011 | US7875290 Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form |
| 01/25/2011 | US7875265 A cosmetic composition comprising a specific block polymer and a specific plasticizer intended to be applied to human keratinous substances, such as the skin, lips, eyelashes, eyebrows, nails or hair; film-forming acrylic polymers containing a plasticizer; flexibility; good hold; transfer-free |
| 01/25/2011 | US7875263 solid alkyl silicone polymers combined with specific liquid esters selected from glyceryl esters, trimethylolpropane esters, and pentaerythritol esters; sun screen actives containing hydroxy acids, antioxidants, flavonoids, tocopherol, vitamins and the like for application to the skin in gelled form |
| 01/25/2011 | US7874995 Reducing or avoiding muscle cramps |
| 01/25/2011 | CA2595385C Pharmaceutical lipid compositions |
| 01/25/2011 | CA2529965C Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases |
| 01/25/2011 | CA2496540C Stable ophthalmic solution comprising latanoprost as active ingredient |
| 01/25/2011 | CA2477557C Stabilized albumin preparations |
| 01/25/2011 | CA2449066C Nicotine-containing film preparation |
| 01/25/2011 | CA2445958C Process for the production of medicinal white oil using m41s and sulfur sorbent |
| 01/25/2011 | CA2436599C Oral pharmaceutical compositions comprising polyvinylpyrrolidone (pvp) and 5-cnac |
| 01/25/2011 | CA2430857C Percutaneous absorption-type pharmaceutical preparation and process for producing the same |
| 01/25/2011 | CA2430182C Prokaryotically produced antibodies and uses thereof |
| 01/25/2011 | CA2410000C Compositions and methods comprising plasmid dna for wound healing and for repairing and regenerating tissue |
| 01/25/2011 | CA2405030C Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| 01/25/2011 | CA2384425C Methods and compositions for delivery of pharmaceutical agents |
| 01/25/2011 | CA2369175C Methods for stabilizing liquid nutritional products and products so stabilized |
| 01/25/2011 | CA2355768C Injectable hyaluronic acid derivative with pharmaceuticals/cells |
| 01/25/2011 | CA2333833C Specific binding molecules for scintigraphy,conjugates containing them and therapeutic method for treatment of angiogenesis |
| 01/22/2011 | CA2710693A1 Pharmaceutical compositions |
| 01/20/2011 | WO2011009106A2 Methods and compositions for in vitro and in vivo chondrogenesis |
| 01/20/2011 | WO2011008992A2 Peptides whose uptake in cells is controllable |
| 01/20/2011 | WO2011008985A2 Methods and compositions for improved delivery of therapeutic and diagnostic agents |
| 01/20/2011 | WO2011008823A2 Peptide-mediated non-covalent delivery of active agents across the blood brain barrier |
| 01/20/2011 | WO2011008183A1 Trimetazidine dihydrochloride-containing medication in the form of an extended-release matrix tablet (variants) and methods for preparing same (variants) |
| 01/20/2011 | WO2011007838A1 Benzimidazole-based injection solution |
| 01/20/2011 | WO2011007824A1 Antitumor composition and method for treating tumors |
| 01/20/2011 | WO2011007795A1 Composition for inhibiting the expression of target gene |
| 01/20/2011 | WO2011007794A1 Zeolite and sericite-containing composition for medical or medical assisting uses |
| 01/20/2011 | WO2011007454A1 Chitosan hydrogel derivatives as a coating agent with broad spectrum of antimicrobial activities |
| 01/20/2011 | WO2011007208A1 Compounds and methods for the treatment of cancer |
| 01/20/2011 | WO2011007153A1 Improvements in and relating to colon cleansing compositions |
| 01/20/2011 | WO2011007148A1 Improved conjugation method |
| 01/20/2011 | WO2011006510A1 Loading technique for preparing radionuclide and ionophore containing liposomes in which the ionophore is 2-hydroxyquionoline (carbostyril) or structurally related 2-hydroxyquinolines |
| 01/20/2011 | WO2011006453A1 Compound lipid based on pentaerythritol, intermediates, preparation method and use thereof |
| 01/20/2011 | WO2010099552A3 Devices, systems and methods for magnetic-assisted therapeutic agent delivery |
| 01/20/2011 | WO2010092088A3 Use of hydrophobin as a spreading agent |
| 01/20/2011 | WO2010059534A3 Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof |
| 01/20/2011 | WO2010030821A3 Ibuprofen for topical administration |
| 01/20/2011 | WO2009146490A8 A method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin k |
| 01/20/2011 | WO2009099830A3 Edible film-strips for immediate release of active ingredients |
| 01/20/2011 | WO2009004595A3 Enhancement of the efficacy of therapeutic proteins |
| 01/20/2011 | US20110015619 Wound dressings for negative pressure therapy in deep wounds and method of using |
| 01/20/2011 | US20110015345 Modified FGF-23 Polypeptides and Their Uses |
| 01/20/2011 | US20110015344 Biodegradable polyacetals for in vivo polynucleotide delivery |
| 01/20/2011 | US20110015280 Ampholytic copolymer, production thereof, and use of the same |
| 01/20/2011 | US20110015266 Lyophilized nanoemulsion |
| 01/20/2011 | US20110015145 Cladribine formulations for improved oral and transmucosal delivery |
| 01/20/2011 | US20110014242 Promoters for expression in modified vaccinia virus ankara |
| 01/20/2011 | US20110014172 Recombinant Human CLN2 Protein and Methods of Its Production and Use |
| 01/20/2011 | US20110014134 Suspension aerosol formulations of pharmaceutical products |
| 01/20/2011 | US20110014130 Method for treatment of solid pharmaceutical preparation prior to printing and solid pharmaceutical preparation subjected to treatment prior to printing |
| 01/20/2011 | US20110014124 Targeted atherosclerosis treatment |
| 01/20/2011 | US20110014122 Novel anti-igf-ir and/or anti-insulin/igf-i hybrid receptors antibodies and uses thereof |